Watson Labs Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WATSON LABS INC, and what generic and branded alternatives to WATSON LABS INC drugs are available?
WATSON LABS INC has seventy-five approved drugs.
There are eleven tentative approvals on WATSON LABS INC drugs.
Drugs and US Patents for Watson Labs Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs Inc | ETOPOSIDE | etoposide | INJECTABLE;INJECTION | 074968-001 | Jan 9, 1998 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Watson Labs Inc | IRBESARTAN | irbesartan | TABLET;ORAL | 090720-002 | Oct 12, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Watson Labs Inc | AMBRISENTAN | ambrisentan | TABLET;ORAL | 208252-001 | Mar 28, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.